'김갑성' 기자의 전체기사
-
Johnson & Johnson Showcases Latest Advancements in…
Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced that new clinical and real-world data from its integrated-by-design VARIPULSE™ Platform in pulsed field ablation (PFA) procedures for atrial fibrillation (AF) will be presented at the Asia Pacific Heart Rhythm Society (APHRS) and the Japanese Heart Rhythm Society (JHRS) joint annual meeting, 12–15 Nov
- 김갑성 기자
- 2025-11-03 14:35
-
Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Bro…
SHANGHAI, Nov. 3, 2025 -- A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus pen needles improves injection stability and user comfort versus conventional narrow hubs in laboratory bench tests. The study measured lower needle deformation and higher anti-tilt resistance under load, attributes that help keep the needle closer to perpendicular for more consistent subcutaneous delivery. These
- 김갑성 기자
- 2025-11-03 14:35
-
Biomom Reinvents "Snow" with Five-Layer Safety Packaging -- St…
SEOUL, South Korea, Nov. 3, 2025 -- Health supplement brand Biomom has introduced upgraded, hygienic packaging for its flagship probiotic "Biomom Snow." The renewal features five-layer safety stick and pillow packaging designed to enhance probiotic protection and ensure a more convenient, safer experience for consumers. Biomom Snow contains 10 billion CFU probiotics per stick, formulated with 19 MFDS-approved strains, and is enriched with Vitamin B complex, Vitamin D, folic acid, biotin, and selenium to provide balanced nutrition for children. Recognizing the se
- 김갑성 기자
- 2025-11-03 14:00
-
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, De…
YONGIN, South Korea, Nov. 3, 2025 -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been published in the international journal Vaccine. BARYTHRAX is the world's first recombinant anthrax vaccine, jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA). This randomized, double-blind, placebo-controlled Phase 2 clinical trial, approved by the Ministry of Food and Drug Safety (MFDS) was condu
- 김갑성 기자
- 2025-11-03 13:26
-
Akeso's Ivonescimab Secures Fourth Breakthrough Therap…
HONG KONG, Nov. 3, 2025 -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) from China's National Medical Products Administration (NMPA). The Phase III multicenter, randomized, double-blind clinical trial (HARMONi-BC1/AK112-308) for this combination therapy is ongoing in China. The BTD designation is expected to further expedite
- 김갑성 기자
- 2025-11-03 12:12
-
MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRE…
MEDAN, Indonesia, Nov. 3, 2025 -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held in Medan, Indonesia. The event serves as one of the largest tourism exhibitions in the country, gathering travel agents, airlines, hotels, medical institutions, and tourism partners under one roof to showcase their offerings and foster cross-border collaboration. As part of the Malaysia Healthcare Pavilion, MHTC leads a delegation of nine (9) world-renowned Malaysian hospitals, further reinforcing
- 김갑성 기자
- 2025-11-03 11:37
-
OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALIS…
SEEB, Oman, Nov. 3, 2025 -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first major Middle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients with Malaysian medical specialists through public exhibitions, clinical consultations and professional exchange, demonstrating Malaysia's "Healing Meets Hospitality" approach to international healthcare. The initiative runs through 5 November in partnership with the Embassy of Malaysia in Oman. IHH Healthcare Group leads the Malaysian
- 김갑성 기자
- 2025-11-03 11:19
-
Oxford Instruments introduces the witec360 Raman Microsco…
LONDON, Nov. 3, 2025 -- Oxford Instruments today announced the launch of its witec360 Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers unprecedented optical performance, automation, and flexibility for research institutions and advanced industries across Singapore and the wider Asia region. Building on the proven heritage of the WITec alpha300 series, the witec360 Raman microscope offers improved light transmission, enhanced automation, and an optimized confocal beam path from laser to dete
- 김갑성 기자
- 2025-11-03 09:00
-
옥스포드 인스트루먼츠, 차세대 라만 현미경 'witec360' 출시
[ 메디채널 김갑성 기자 ] 런던 2025년 11월 3일 -- 옥스포드 인스트루먼츠(Oxford Instruments)는 'Hexalight 분광기'가 장착된 'witec360 라만 현미경'을 공식 출시했다. 이번 신제품은 기존 alpha300 시리즈의 성능을 한층 강화한 모델로, 향상된 광학 효율성과 자동화 기능을 통해 연구자들이 시료를 더 빠르고 정확하게 분석할 수 있도록 설계됐다. WITec 기술의 혁신을 계승한 witec360 witec360 라만 현미경은 2021년 옥스포드 인스트루먼츠에 합류한 독일의 선도 기업 WITec(비텍)의 기술 혁신을 집대성한 제품이다. WITec의 기술 유산을 이어받은 이번 모델은 레이저에서 검출기까지 완전히 최적화된 공초점 빔 경로를 구현했으며, 백색광 관찰과 라만 데이터 획득 간 모터 구동 전환이 가능해 효율적인 데이터 수집을 지원한다. 이 시스템은 표준형과 역광 경로형을 포함해 다양한 구성과 자동화 수준으로 제공되며, 실험 목적과 연구 환경에 맞게 모듈식으로 확장할 수 있다. 이를 통해 재료과학, 생명과학, 반도체 연구 등
- 김갑성 기자
- 2025-11-03 08:00
-
Caregility and MOD3RN Care Partner to Modernise Healthcare D…
WALL, N.J. and BARANGAROO, Australia, Nov. 3, 2025 -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered solutions, today announced a strategic reseller partnership with MOD3RN Care, a leading Australia-based technology solutions provider. The collaboration aims to accelerate the adoption of virtual care and AI-enabled care models across Australia to strengthen clinical capacity, improve patient safety, and reduce staff burnout. The partnership aligns wi
- 김갑성 기자
- 2025-11-03 05:30
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-12_FRI
- His Excellency affirmed that NDF has achieved significant international development milestones over the past fifty years, including more than USD 40 billion in assistance 01:35
- ZOWIE Elevates Esports Performance at Budapest Major 2025 01:00
- TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 00:21
- ACE Shutters Notorious Piracy Operations in India 00:01
- Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix® 00:00
- Gravity Launches Hybrid Casual Game 'Ragnarok Monster Kitchen' Worldwide! 00:00
2025-12-11_THU
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 12일 03시 00분